促销时间表 ADC Therapeutics SA
先进的时间表
简单图表
关于公司 ADC Therapeutics SA
ADC Therapeutics SA, биотехнологическая компания, специализирующаяся на клинических онкологиях, разрабатывает конъюгаты антител и лекарств (ADC) для пациентов, страдающих гематологическими злокачественными новообразованиями и солидными опухолями. 更多详情| IPO date | 1979-03-16 |
|---|---|
| ISIN | CH0499880968 |
| Industry | Communications Equipment |
| Sector | Information Technology |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.adctherapeutics.com |
| Цена ао | 1.48 |
| 每日价格变化: | 0% (1.48) |
|---|---|
| 每周价格变化: | -8.64% (1.62) |
| 每月价格变化: | -13.45% (1.71) |
| 3个月内价格变化: | -44.15% (2.65) |
| 六个月内的价格变化: | -46.95% (2.79) |
| 每年价格变化: | -69.55% (4.86) |
| 3年内价格变化: | -89.98% (14.77) |
| 5年内价格变化: | 0% (1.48) |
| 10年价格变化: | 0% (1.48) |
| 年初以来价格变化: | -25.63% (1.99) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
|---|---|---|---|---|---|---|---|---|---|
| 04.12.2024 | 06.12.2024 | Redmile Group, LLC 10% Owner |
销售 | 2.07 | 52 479 | 25352 | 0 | -0.03 | 关联 |
| 17.06.2024 | 18.06.2024 | Squarer Ron Director |
销售 | 2.89 | 20 216 | 6995 | 0 | -0.01 | 关联 |
| 17.06.2024 | 18.06.2024 | Sandor Victor Director |
销售 | 2.89 | 20 216 | 6995 | 0 | -0.01 | 关联 |
| 17.06.2024 | 18.06.2024 | Pfisterer Thomas Director |
销售 | 2.89 | 4 153 | 1437 | 0 | 0 | 关联 |
| 17.06.2024 | 18.06.2024 | Monges Viviane Director |
销售 | 2.89 | 4 153 | 1437 | 0 | 0 | 关联 |
| 17.06.2024 | 18.06.2024 | Hug Peter Director |
销售 | 2.89 | 3 448 | 1193 | 0 | 0 | 关联 |
| 07.05.2024 | 09.05.2024 | MALLIK AMEET Chief Executive Officer |
销售 | 4.48 | 133 195 | 29731 | 0 | -0.04 | 关联 |
| 机构 | 体积 | 分享, % |
|---|---|---|
| Redmile Group, LLC | 15328317 | 18.57 |
| Prosight Management, LP | 6471800 | 7.84 |
| Millennium Management LLC | 2672810 | 3.24 |
| Citadel Advisors Llc | 1853412 | 2.25 |
| Bank of America Corporation | 1525741 | 1.85 |
| Goldman Sachs Group Inc | 1459514 | 1.77 |
| Affinity Asset Advisors, LLC | 1013540 | 1.23 |
| Vantage Consulting Group, Inc | 850737 | 1.03 |
| Morgan Stanley | 781937 | 0.95 |
| Blue Owl Capital Holdings LP | 733568 | 0.89 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.06858 | 17.09 | 1.54048 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.0228 | 31.36 | 1.41955 |
iShares Russell 2000 Growth ETF
|
0.01199 | 38.04 | 0.6026 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
ProShares UltraPro Russell2000
|
0.00504 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00133 | 5.92 | 1.47892 |
| iShares Russell 3000 ETF | 0.00106 | 24.83 | 1.43482 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Amanda Hamilton | Investor Relations Officer | N/A | |
| Ms. Kimberly Pope | Senior VP & Chief People Officer | N/A | 1967 (58 年) |
| Dr. Ameet Mallik M.B.A., M.S. | CEO & Director | 1.84M | 1973 (52 年) |
| Mr. Jose I. Carmona M.B.A. | Chief Financial Officer | 884.86k | 1972 (53 年) |
| Dr. Michael Mulkerrin Ph.D. | Chief Technical Operations Officer | N/A | 1955 (70 年) |
| Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer | N/A | 1969 (56 年) |
| Mr. Peter J. Graham Esq. | Secretary & Chief Legal Officer | N/A | 1967 (58 年) |
| Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer | 2.41M | 1965 (60 年) |
| Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer | N/A | |
| Ms. Eugenia Litz | Vice President of Investor Relations & Corporate Communications | N/A |
地址: Switzerland, Epalinges , Biopole - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.adctherapeutics.com
网站: http://www.adctherapeutics.com
